Here are the S-3 shelf registrations from Assembly Biosciences, Inc (ASMB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow ASMB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASMB filings page.
Assembly Biosciences, Inc. registered securities for an aggregate offering price of $400,000,000 under a shelf prospectus, and the related prospectus supplement covers up to $100,000,000 of common stock to be sold on an at-the-market basis.
The prospectus describes the types of securities that may be offered — common stock, preferred stock, debt securities, warrants, subscription rights and units — and states that specific terms will be provided in prospectus supplements. The supplement establishes an Open Market Sale Agreement with Jefferies LLC as sales agent for the $100,000,000 ATM program, and reports a last reported Nasdaq sale price of $27.52 per share as of March 18, 2026.